<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84056</article-id><article-id pub-id-type="doi">10.7554/eLife.84056</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Evaluation of antibody kinetics and durability in health individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-295165"><name><surname>Zhang</surname><given-names>Hangjie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7334-2536</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297375"><name><surname>Hua</surname><given-names>Qianhui</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297376"><name><surname>Nani Xu</surname><given-names>Nani</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297377"><name><surname>Zhang</surname><given-names>Xinpei</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297378"><name><surname>Chen</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297379"><name><surname>Ma</surname><given-names>Xijun</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297380"><name><surname>Hu</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297381"><name><surname>Chen</surname><given-names>Zhongbing</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297382"><name><surname>Yu</surname><given-names>Pengfei</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297383"><name><surname>Lei</surname><given-names>Huijun</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297384"><name><surname>Wang</surname><given-names>Shenyu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297385"><name><surname>Ding</surname><given-names>Linling</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297386"><name><surname>Fu</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297387"><name><surname>Liao</surname><given-names>Yuting</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-297388"><name><surname>Yang</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-297389"><name><surname>Jiang</surname><given-names>Jianmin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-297390"><name><surname>Lv</surname><given-names>Huakun</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3420-6942</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Immunization Program</institution>, <institution>Zhejiang Provincial Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">School of Medicine</institution>, <institution>Ningbo University</institution>, <addr-line><named-content content-type="city">Ningbo</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution>Xihu District Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution>Shangyu District Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Shaoxing</named-content></addr-line>, <country>China</country></aff><aff id="aff5"><institution>Kaihua District Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Quzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff6"><institution>Yuecheng District Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Shaoxing</named-content></addr-line>, <country>China</country></aff><aff id="aff7"><institution content-type="dept">Department of Immunization Program</institution>, <institution>Jiaxing Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Jiaxing</named-content></addr-line>, <country>China</country></aff><aff id="aff8"><institution>Longyou District Center for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Quzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff9"><institution content-type="dept">School of Public Health</institution>, <institution>Xiamen University</institution>, <addr-line><named-content content-type="city">Xiamen</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-33388"><name><surname>Sigal</surname><given-names>Alex</given-names></name><role>Reviewing editor</role><aff><institution>Africa Health Research Institute</institution>, <country>South Africa</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jmjiang@cdc.zj.cn</email> (JJ);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>hklv@cdc.zj.cn</email> (HL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e84056</elocation-id><history><date date-type="received"><day>09</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>20</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Zhang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zhang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84056-v1.pdf"/><abstract><p><bold>Background:</bold> Although inactivated COVID-19 vaccines are proven to be safe and effective in the general population, the dynamic response and duration of antibodies after vaccination in the real world should be further assessed.</p><p><bold>Methods:</bold> We enrolled 1067 volunteers who had been vaccinated with one or two doses of CoronaVac in Zhejiang Province, China. Another 90 healthy adults without previous vaccinations were recruited and vaccinated with three doses of CoronaVac, 28 days and 6 months apart. Serum samples were collected from multiple timepoints and analyzed for specific IgM/IgG and neutralizing antibodies (NAbs) for immunogenicity evaluation. Antibody responses to the Delta and Omicron variants were measured by pseudovirus-based neutralization tests.</p><p><bold>Results:</bold> Our results revealed that binding antibody IgM peaked 14-28 days after one dose of CoronaVac, while IgG and NAbs peaked approximately 1 month after the second dose then declined slightly over time. Antibody responses had waned by month 6 after vaccination and became undetectable in the majority of individuals at 12 months. Levels of NAbs to live SARS-CoV-2 were correlated with anti-SARS-CoV-2 IgG and NAbs to pseudovirus, but not IgM. Homologous booster around 6 months after primary vaccination activated anamnestic immunity and raised NAbs 25.5-fold. The neutralized fraction subsequently rose to 36.0% for Delta (p=0.03) and 4.3% for Omicron (p=0.004), and the response rate for Omicron rose from 7.9% (7/89) to 17.8% (16/90).</p><p><bold>Conclusions:</bold> Two doses of CoronaVac vaccine resulted in limited protection over a short duration. The inactivated vaccine booster can reverse the decrease of antibody levels to prime strain, but it does not elicit potent neutralization against Omicron; therefore, the optimization of booster procedures is vital.</p><p><bold>Funding:</bold> Key Research and Development Program of Zhejiang Province; Key Program of Health Commission of Zhejiang Province/ Science Foundation of National Health Commission; Major Program of Zhejiang Municipal Natural Science Foundation; Explorer Program of Zhejiang Municipal Natural Science Foundation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Key Research and Development Program of Zhejiang Province, 2021C03200</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zhang</surname><given-names>Hangjie</given-names></name><name><surname>Nani Xu</surname><given-names>Nani</given-names></name><name><surname>Chen</surname><given-names>Bo</given-names></name><name><surname>Liao</surname><given-names>Yuting</given-names></name><name><surname>Yang</surname><given-names>Juan</given-names></name><name><surname>Jiang</surname><given-names>Jianmin</given-names></name><name><surname>Lv</surname><given-names>Huakun</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Key Program of Health Commission of Zhejiang Province/ Science Foundation of National Health Commission, WKJ-ZJ-2221</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Jiang</surname><given-names>Jianmin</given-names></name><name><surname>Lv</surname><given-names>Huakun</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Major program of Zhejiang Municipal Natural Science Foundation, LD22H190001</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zhang</surname><given-names>Hangjie</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Explorer Program of Zhejiang Municipal Natural Science Foundation, LQ23H00001</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zhang</surname><given-names>Hangjie</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: We state that we conformed with the Helsinki Declaration of 1975 (as revised in 2008) concerning Human and Animal Rights, and that we followed out the policy concerning Informed Consent as shown on Springer.com. The study protocol and informed consent form were approved by the Medical Ethics Committee of The Zhejiang Center for Disease Control and Prevention (2021-044-01). Written informed consent was obtained from all study participants.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in this published article and its supplementary information files, or are available in database Dryad (https://datadryad.org/).</p></sec><supplementary-material><ext-link xlink:href="elife-84056-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>